Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Hematology & Oncology
|
November 10, 2020
Emerging agents and regimens for multiple myeloma
Yang Yang, Yi Li, Huiyao Gu, et al.
Journal of Materials Chemistry. B
|
February 6, 2023
Calcium silicate/bortezomib combinatory therapy for multiple myeloma
Liqin Cao, Huiyao Gu, Zhaowenbing Zhang, et al.
Biomarker Research
|
January 7, 2021
Metabolic reprogramming in macrophage responses
Yang Liu, Ruyi Xu, Huiyao Gu, et al.
Cancer Immunology, Immunotherapy : CII
|
July 26, 2022
Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myeloma
Haimeng Yan, Donghua He, Jianwei Qu, et al.
International Journal of Cancer
|
August 8, 2019
The NEDD4-1 E3 ubiquitin ligase: A potential molecular target for bortezomib sensitivity in multiple myeloma
Xi Huang, Huiyao Gu, Enfan Zhang, et al.
Clinical Epigenetics
|
July 7, 2022
Chidamide and venetoclax synergistically exert cytotoxicity on multiple myeloma by upregulating BIM expression
Liqin Cao, Qingxiao Chen, Huiyao Gu, et al.
Oxidative Medicine and Cellular Longevity
|
September 4, 2020
Dihydroartemisinin Modulates Apoptosis and Autophagy in Multiple Myeloma through the P38/MAPK and Wnt/<i>β</i>-Catenin Signaling Pathways
Xiuhua Wu, Yang Liu, Enfan Zhang, et al.
Oncoimmunology
|
April 4, 2022
Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
Yang Liu, Haimeng Yan, Huiyao Gu, et al.
Oncogene
|
November 11, 2021
RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways
Jianwei Qu, Yifan Hou, Qingxiao Chen, et al.
Haematologica
|
May 19, 2018
Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease
Jingsong He, Qingxiao Chen, Huiyao Gu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Hematology & Oncology
|
November 10, 2020
Emerging agents and regimens for multiple myeloma
Yang Yang, Yi Li, Huiyao Gu, et al.
Journal of Materials Chemistry. B
|
February 6, 2023
Calcium silicate/bortezomib combinatory therapy for multiple myeloma
Liqin Cao, Huiyao Gu, Zhaowenbing Zhang, et al.
Biomarker Research
|
January 7, 2021
Metabolic reprogramming in macrophage responses
Yang Liu, Ruyi Xu, Huiyao Gu, et al.
Cancer Immunology, Immunotherapy : CII
|
July 26, 2022
Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myeloma
Haimeng Yan, Donghua He, Jianwei Qu, et al.
International Journal of Cancer
|
August 8, 2019
The NEDD4-1 E3 ubiquitin ligase: A potential molecular target for bortezomib sensitivity in multiple myeloma
Xi Huang, Huiyao Gu, Enfan Zhang, et al.
Clinical Epigenetics
|
July 7, 2022
Chidamide and venetoclax synergistically exert cytotoxicity on multiple myeloma by upregulating BIM expression
Liqin Cao, Qingxiao Chen, Huiyao Gu, et al.
Oxidative Medicine and Cellular Longevity
|
September 4, 2020
Dihydroartemisinin Modulates Apoptosis and Autophagy in Multiple Myeloma through the P38/MAPK and Wnt/<i>β</i>-Catenin Signaling Pathways
Xiuhua Wu, Yang Liu, Enfan Zhang, et al.
Oncoimmunology
|
April 4, 2022
Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
Yang Liu, Haimeng Yan, Huiyao Gu, et al.
Oncogene
|
November 11, 2021
RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways
Jianwei Qu, Yifan Hou, Qingxiao Chen, et al.
Haematologica
|
May 19, 2018
Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease
Jingsong He, Qingxiao Chen, Huiyao Gu, et al.
Page
of 2